Leap Investments’s Surgery Partners SGRY Stock Holding History

Leap Investments’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,800	Closed	-$129K	–	542
2020 Q1	$129K	Buy	+19,800	New	+$282K	0.19%	224

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

KSCM

King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Leap Investments's SGRY Position: Q2 2020 in Review

Leap Investments sold out of Surgery Partners (SGRY) in Q2 2020, closing a stake of 19,800 shares — an estimated $129K sold.

Leap Investments first reported a position in SGRY in Q1 2020 and held it in 1 quarter. The position peaked at $129K in Q1 2020. 98 funds tracked by Wall St. Rank hold SGRY as of Q2 2020.

Leap Investments reported no remaining Surgery Partners position as of Q2 2020 after selling out during the quarter.
Leap Investments sold 19,800 Surgery Partners shares in Q2 2020, an estimated $129K.
Leap Investments first reported a position in Surgery Partners in Q1 2020 and held it in 1 quarter.
Leap Investments's Surgery Partners position peaked at $129K in Q1 2020.
98 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.